CTRI/2010/091/001390招募中2 期
Phase-2 comparative clinical trial to assess the efficacy and safety of sodium nitroprusside inhalation in treatment of secondary pulmonary hypertension & hypoxemic conditions (as a life saving/supporting procedure)
Defence R&D Organisation0 个研究点目标入组 135 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 135
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a) Healthy volunteers
- •1. Healthy Males/females, between 18-45 years ages group
- •2. On no permanent treatment
- •3. Suffering from no permanent / recurrent / chronic disease or disability
- •b) Diseased subjects
- •1. Worked up adult patients with pulmonary hypertension with associated mild or moderate asthma or COPD or ILD with hypoxemia. Wherever facilities are not available, for example at high altitude, clinical diagnosis shall be deemed sufficient as per accepted norms.
- •2. Age group: 18-65 years
- •3. Ambulatory, preferably admitted patients for better follow up
- •4. Non-critically ill patients.
排除标准
- •a) Healthy volunteers
- •1. Those who do not sign the ICF
- •2. Those who refuse to abide by the rules/briefing and are not able to inhale aerosols as per instructions.
- •3. Those who have had any medical condition which in the judgement of the investigator may render them inappropriate for participation in the trial.
- •4. Patients who have received any other investigational drug for the last 1 month.
- •5. Too low or too high body weight (< 40 kg, > 100 kg)
- •6. Pregnant & lactating women
- •b) Diseased subjects
- •1. Patients with prior hypersensitivity to nitrates
- •2. Patients who are unwilling to give informed consent.
- •3. Patients receiving oral or systemic nitric acid donors or known to have increased indigenous nitric oxide production within 4 weeks of the start of the study.
- •4. Patients on continuous oxygen with cyanosis or respiratory failure or on ventilatory support with minimal response (relative criteria ? may be included as a life-saving measure with appropriate written disclosures and disclaimers)
- •5. Volunteers with serious or critical illness.
- •6. Patients who are pregnant, lactating or women of child bearing potential not using medically accepted methods of contraception.
- •7. Patients with clinically significant renal, respiratory (other than those mentioned), cardiac (including rheumatic or congenital heart disease), gastrointestinal, hepatic, endocrine or hematological disorders.
- •8. Patients who have any medical condition which in the judgement of the investigator may render them inappropriate for participation in the trial.
- •9. Patients who have received any other investigational drug for the last 1 month.
研究者
相似试验
招募中
2 期
A clinical trial to assess the efficacy and safety of sodium nitrite inhalation in treatment of secondary pulmonary hypertension & hypoxemic conditionsCTRI/2010/091/001389Defence R&D Organisation158
尚未招募
2 期
To study the effect of TILAKUSUMADILEPA in skin diseaseCTRI/2022/01/039662Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik
尚未招募
2 期
To study the effect of application of Durvadya taila in Eczema.CTRI/2020/09/028010Ayurved Mahavidyalaya Nashik
尚未招募
2 期
Study the effect of decoction of pippal bark and Guduchi in pain and swelling in leg jointsCTRI/2020/09/027991Ayurved Mahavidyalaya Nashik
尚未招募
2 期
Study of effect of siddharthakadi lepa and vamankarma in volunteers having pimplesCTRI/2020/11/028881Dr Shraddha Dnyandev Patil